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LETTER TO THE EDITOR
DNA methylation: Atherosclerosis leading to congenital heart diseases
Sher Khan, Rehana Rehman
Madam,
Congenital
heart
diseases (CHD) are the problems
that cover the most common
type of deformity during birth.
The problems could possibly be
the accumulation of plaque in the
arteries of heart that minimize
the supply of oxygen rich blood
to the heart muscles thus
preventing it from normal
workout. Common defects are
found inside the walls and valves
of heart or the enlarged blood
vessels that carry blood towards
and from the heart. The CHD can
range from simple to much
complex
and
disparaging
conditions. CHD takes place in
the foetus due to the changes in
DNA mutations in particular
genes that are inherited. The
Figure: DNA methylatoin mechanism.
molecular mechanisms resulting
in CHD are multiplex. Several
shown substantial findings regarding association
factors can play a part in the development of CHD such as
between them. Several DNA methylation approaches
genetic susceptibility, epigenetic mechanism and
1
have been used which differ from one another
environmental effects. Among these factors DNA
illustrating the mechanism which include global DNA
methylation is much known to be associated with CHD,
methylation, candidate gene and epigenome-wide
that take place during pregnancy.
association studies. CHD has been reportedly linked
Epigenetic modifications in the genome such as DNA
with Antisense non-coding RNA in the INK4 locus
methylation have been suggested to play a role in the
(ANRIL) premotor DNA methylation.4 The differences
processes involved in cardiovascular diseases. DNA
in DNA methylation in vascular tissues with coronary
methylation is one of the forms of epigenetic gene
artery disease may provide insight into the
regulation.2 This process involves the incorporation of
mechanisms underlying the development of
methyl group at the C5 position of cytosine altering the
atherosclerosis.
pattern of DNA producing possible changes in the gene
Since the studies are ongoing on association between
expression.3 DNA methylation is an epigenetic gadget
DNA methylation and their consequences in the
that determines whether or not a gene is expressed,
presentation of CHD, it is expected that the newly
guides stem cells as they get a shape of specialized cells
developed tools like next generation sequences
from blank slates.
techniques and further workout on demethylation
The association between CHD and DNA methylation is
phenomenon may help us to explore new ways in
not understood clearly, however many studies have
sorting out the exact epigenetics mechanism of CHD
thus helping us in the treatment of complicated heart
diseases. DNA methylation abnormalities involved in
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CHD once explored may help in prediction of
Correspondence: Rehana Rehman. Email: drrehana7@gmail.com
Vol. 69, No. 1, January 2019

138

S. Khan, R. Rehman

atherosclerosis leading to CHD.
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